DK317287D0 - Reduktase-inhibitorer - Google Patents
Reduktase-inhibitorerInfo
- Publication number
- DK317287D0 DK317287D0 DK317287A DK317287A DK317287D0 DK 317287 D0 DK317287 D0 DK 317287D0 DK 317287 A DK317287 A DK 317287A DK 317287 A DK317287 A DK 317287A DK 317287 D0 DK317287 D0 DK 317287D0
- Authority
- DK
- Denmark
- Prior art keywords
- reductase inhibitors
- reductase
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/365—Nocardia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87704186A | 1986-06-23 | 1986-06-23 | |
US193387A | 1987-01-09 | 1987-01-09 | |
US4813687A | 1987-05-15 | 1987-05-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK317287D0 true DK317287D0 (da) | 1987-06-22 |
DK317287A DK317287A (da) | 1987-12-24 |
Family
ID=27357040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK317287A DK317287A (da) | 1986-06-23 | 1987-06-22 | Hmg-coa-reduktaseinhibitorer samt et farmaceutisk praeparat, der indeholder disse |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0251625B1 (da) |
KR (1) | KR880000586A (da) |
AU (1) | AU7455987A (da) |
CA (1) | CA1340331C (da) |
DE (1) | DE3770345D1 (da) |
DK (1) | DK317287A (da) |
PT (1) | PT85109A (da) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4833258A (en) * | 1987-02-17 | 1989-05-23 | Merck & Co., Inc. | Intermediates useful in the preparation of HMG-COA reductase inhibitors |
US4795811A (en) * | 1987-06-22 | 1989-01-03 | Merck & Co., Inc. | Intermediates for preparing HMG-CoA reductase inhibitors |
PT88364A (pt) * | 1987-09-02 | 1989-07-31 | Merck & Co Inc | Process for preparing novel hmg-coa reductase inhibitors |
DE3869282D1 (de) * | 1987-09-02 | 1992-04-23 | Merck & Co Inc | Inhibitoren von hmg-coa-reduktase. |
US4841074A (en) * | 1987-12-11 | 1989-06-20 | Merck & Co., Inc. | Intermediates and processes for 6-carboxy HMG-CoA reductase inhibitors |
US4857547A (en) * | 1988-01-07 | 1989-08-15 | Merck & Co., Inc. | Novel HMG-CoA reductase inhibitors |
US4866090A (en) * | 1988-01-07 | 1989-09-12 | Merck & Co., Inc. | Novel HMG-CoA reductase inhibitors |
US4857546A (en) * | 1988-01-07 | 1989-08-15 | Merck & Co., Inc. | Novel HMG-CoA reductase inhibitors |
US4866068A (en) * | 1988-02-01 | 1989-09-12 | Merck & Co., Inc. | Novel HMG-CoA reductase inhibitors |
US4946864A (en) * | 1988-02-01 | 1990-08-07 | Merck & Co., Inc. | Novel HMG-CoA reductase inhibitors |
US5049696A (en) * | 1988-04-11 | 1991-09-17 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
US4997755A (en) * | 1988-04-15 | 1991-03-05 | Merck & Co., Inc. | HMG-CoA reductase inhibitors produced by Nocardia sp. (MA 6455) |
EP0337548A3 (en) * | 1988-04-15 | 1991-08-14 | Merck & Co. Inc. | HMG-COA reductase inhibitors produced by nocardia SP. (MA6455)(ATCC 53695) |
FI893004A (fi) * | 1988-06-29 | 1989-12-30 | Merck & Co Inc | 5-oxygenerade hmg-coa-reduktas -inhibitorer. |
US4916239A (en) * | 1988-07-19 | 1990-04-10 | Merck & Co., Inc. | Process for the lactonization of mevinic acids and analogs thereof |
CA2009043A1 (en) * | 1989-02-01 | 1990-08-01 | Michael J. Ferris | Process for the preparation of 6-alpha-hydroxymethyl lovastatin derivatives |
US5001148A (en) * | 1989-06-07 | 1991-03-19 | E. R. Squibb & Sons, Inc. | Mevinic acid derivatives |
IL90847A0 (en) * | 1989-06-09 | 1990-02-09 | Merck & Co Inc | 3-keto hmg-coa reductase inhibitors and pharmaceutical compositions containing them |
GB8915280D0 (en) * | 1989-07-04 | 1989-08-23 | British Bio Technology | Compounds |
FI94339C (fi) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
US5089523A (en) * | 1990-05-11 | 1992-02-18 | E. R. Squibb & Sons, Inc. | Fluorinated derivatives of mevinic acids |
US5264455A (en) * | 1990-07-06 | 1993-11-23 | E. R. Squibb & Sons, Inc. | Sulfur-substituted mevinic acid derivatives |
GB9100174D0 (en) * | 1991-01-04 | 1991-02-20 | British Bio Technology | Compounds |
GB9111192D0 (en) * | 1991-05-23 | 1991-07-17 | British Bio Technology | Synthetic process |
US5286746A (en) * | 1991-12-20 | 1994-02-15 | E. R. Squibb & Sons, Inc. | Sulfur-substituted mevinic acid derivatives |
US6043064A (en) * | 1993-10-22 | 2000-03-28 | Bristol-Myers Squibb Company | Enzymatic hydroxylation process for the preparation of HMG-CoA reductase inhibitors and intermediates thereof |
SI9800046A (sl) * | 1998-02-18 | 1999-08-31 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze visoke čistosti |
AU4543699A (en) * | 1998-06-08 | 1999-12-30 | Advanced Medicine, Inc. | Multibinding inhibitors of hmg-coa reductase |
PL346392A1 (en) * | 1999-06-29 | 2002-02-11 | Kaneka Corp | Process for selective lactonization |
US20210008084A1 (en) | 2017-10-16 | 2021-01-14 | Tsinghua University | Mevalonate pathway inhibitor and pharmaceutical composition thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5835144A (ja) * | 1981-08-27 | 1983-03-01 | Sankyo Co Ltd | Mb−530b誘導体およびその製造法 |
US4611068A (en) * | 1984-11-19 | 1986-09-09 | Merck Frosst Canada, Inc. | Process for the preparation of HMG-CoA reductase inhibitors and intermediate compounds employed therein |
-
1987
- 1987-06-17 PT PT85109A patent/PT85109A/pt unknown
- 1987-06-19 CA CA000540097A patent/CA1340331C/en not_active Expired - Fee Related
- 1987-06-22 DK DK317287A patent/DK317287A/da not_active Application Discontinuation
- 1987-06-22 AU AU74559/87A patent/AU7455987A/en not_active Abandoned
- 1987-06-22 DE DE8787305527T patent/DE3770345D1/de not_active Expired - Fee Related
- 1987-06-22 EP EP87305527A patent/EP0251625B1/en not_active Expired - Lifetime
- 1987-06-22 KR KR1019870006305A patent/KR880000586A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE3770345D1 (de) | 1991-07-04 |
EP0251625A3 (en) | 1989-01-25 |
CA1340331C (en) | 1999-01-26 |
PT85109A (en) | 1987-07-01 |
AU7455987A (en) | 1987-12-24 |
DK317287A (da) | 1987-12-24 |
EP0251625A2 (en) | 1988-01-07 |
EP0251625B1 (en) | 1991-05-29 |
KR880000586A (ko) | 1988-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK317287D0 (da) | Reduktase-inhibitorer | |
DE3681991D1 (de) | Hmg-coa-reduktase-hemmungskoerper. | |
ATE97652T1 (de) | Peptidasehemmungsmittel. | |
DK674387A (da) | Proteaseinhibitorer | |
DK226888A (da) | Steroid 5-alfa-reduktase inhibitor | |
DE3864608D1 (de) | Hmg-coa-reduktasehemmer. | |
DK640388D0 (da) | Pyrimidinderivater | |
DK247889D0 (da) | Pyrimidinderivater | |
DE68904083D1 (de) | Hmg-coa-reduktaseinhibitoren. | |
BR8907457A (pt) | Inibidores de interleucina-1 | |
DE68901091D1 (de) | Hmg-coa-reduktaseinhibitoren. | |
MX9203768A (es) | Inhibidores novedosos de reductasa 3-hidroxi-metilglutaril-coenzima a. | |
DE3674131D1 (de) | Substituierte dihalo-statin-reninhemmungsmittel. | |
DK0409676T3 (da) | Acetylcholinesterase-inhibitorer | |
DK349586A (da) | Enzyminhibitor | |
DK584288D0 (da) | Saerlig fremgangsmaade | |
FI101796B1 (fi) | Uusia -glukosidaasi-inhibiittoreita | |
DK227388D0 (da) | Pyrimidinderivater | |
NO864337D0 (no) | Dopamin-beta-hydrolase-inhibitorer. | |
DK174087D0 (da) | Angiotensinkonverterende enzyminhibitor | |
DK314988D0 (da) | Saerlig fremgangsmaade | |
NO860960L (no) | Avsetningsinhibitorer. | |
DK440887A (da) | Dopamin-beta-hydroxylase-inhibitorer | |
DK69489A (da) | Aspartattranscarbamylase-inhibitorer | |
NO872985L (no) | Inhibitor for polyuretanpropergoler. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |